FDA Clearance Tracker · P010014
OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 21, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Apr 21, 2004
Approved
Time to decision
1,147 days
Received Mar 1, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P010014
- Device name
- OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
- Applicant
- Biomet Manufacturing Corp
- Applicant location
- Warsaw, IN
- Received
- Mar 1, 2001
- Decided
- Apr 21, 2004
- Decision
- Approved
- Supplements
- 108 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE OXFORD MENISCAL UNICOMPARTMENTAL KNEE SYSTEM (PHASE 3). THE DEVICE IS INDICATED FOR USE IN PATIENTS WITH OSTEOARTHRITIS OR AVASCULAR NECROSIS LIMITED TO THE MEDIAL COMPARTMENT OF THE KNEE AND INTENDED TO BE IMPLANTED WITH BONE CEMENT.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NRA. The earliest in FDA's data is P910016, decided Oct 30, 1992.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Biomet Manufacturing Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Oxford Cementless Partial Knee SystemPMA supplement
P010014-S105 · Decided Nov 22, 2024 · 536 days after receipt · Panel Track
Device type: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing (NRA) · Orthopedic Surgery
K230540 · Decided Jul 25, 2023 · 148 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
K214001 · Decided Mar 15, 2023 · 449 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.